For instance, miR-206 was shown to be down-regulated in CDDP-resistant lung cancer cells, and overexpression of miR-206 reversed the mesenchymal features and sensitized CDDP-resistant cells to CDDP via targeting MET (24). Here, MET is linked to lung carcinoma.